GPR120 Ameliorates Apoptosis and Inhibits the Production of Inflammatory Cytokines in Renal Tubular Epithelial Cells
Authors:
- 3 October 2020
- journal article
- research article
- Published by Springer Nature in Inflammation
- Vol. 44 (2) , 493-505
Abstract
Acute kidney injury (AKI) is the most common complication of sepsis with a high mortality rate. In this study, we focus on the renal injury caused by the immune response of renal tubular epithelial cells and inflammation-induced renal tubular epithelial cell apoptosis. We studied the role of GRP120 in the inflammation and apoptosis of human renal cell line HK-2 and mouse primary renal tubular epithelial cells. GPR120 agonist GW9508 activated the GPR120 pathway. Inflammatory factors were detected using quantitative real-time PCR and enzyme-linked immunosorbent assay. Cell apoptosis experiments included the annexin V and PI double-staining method combined with flow cytometry, TUNEL method, and Western blot. The level of cytokines including TNF-α, IL-6, IL-1β, and iNOS was significantly decreased (P < 0.05) in HK-2 and TECs after the activation of the GPR120 pathway. Besides, the cell apoptosis of both cells increased. Overexpressed GPR120 and shGPR120 were established. Treatment with lipopolysaccharide (LPS) increased the level of cytokines including TNF-α, IL-6, IL-1β, and iNOS in HK-2 cell and TECs. Compared with control-LPS and negative control (NC)-LPS, the overexpression of GPR120 and shGPR120 could decrease and increase the level of secreted cytokines significantly (P < 0.05), respectively, after LPS-induced apoptosis. After H2O2- and LPS-induced apoptosis, respectively, compared with the control and NC groups, overexpressed GPR120 and shGPR120 could reduce and increase the expression of caspase-3, respectively. GPR120 could suppress the cellular immune response and apoptosis in renal tubular epithelial cells, thereby possibly protecting the kidney and relieving sepsis-induced AKI.Keywords
Funding Information
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding (ZYLX201802)
This publication has 40 references indexed in Scilit:
- Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and SepsisNew England Journal of Medicine, 2018
- Sepsis and septic shockThe Lancet, 2018
- Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial CellsJournal of Visualized Experiments, 2018
- Mortality and morbidity in community-acquired sepsis in European pediatric intensive care units: a prospective cohort study from the European Childhood Life-threatening Infectious Disease Study (EUCLIDS)Critical Care, 2018
- Physiological aspects of Toll‐like receptor 4 activation in sepsis‐induced acute kidney injuryActa Physiologica, 2016
- Eicosapentaenoic acid attenuates dexamethasome-induced apoptosis by inducing adaptive autophagy via GPR120 in murine bone marrow-derived mesenchymal stem cellsCell Death & Disease, 2016
- Cellular and Molecular Mechanisms of AKIJournal of the American Society of Nephrology, 2016
- The Global Epidemiology of Sepsis. Does It Matter That We Know So Little?American Journal of Respiratory and Critical Care Medicine, 2016
- Ginsenoside-Rb2 Inhibits Dexamethasone-Induced Apoptosis Through Promotion of GPR120 Induction in Bone Marrow-Derived Mesenchymal Stem CellsStem Cells and Development, 2015
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011